In summary, T2DM patients and the patients with diabetic complication have decreased immunosuppressive CD4+CD25+Foxp3+Treg cells and increased proinflammatory IL-10, TGF-β, and TNF-α. This evidence concerns the gene TGFB1 and type 2 diabetes mellitus.